ZA851927B - Pharmaceutical composition containing 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxy preggna-1,4-diene-3,20-dione - Google Patents

Pharmaceutical composition containing 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxy preggna-1,4-diene-3,20-dione

Info

Publication number
ZA851927B
ZA851927B ZA851927A ZA851927A ZA851927B ZA 851927 B ZA851927 B ZA 851927B ZA 851927 A ZA851927 A ZA 851927A ZA 851927 A ZA851927 A ZA 851927A ZA 851927 B ZA851927 B ZA 851927B
Authority
ZA
South Africa
Prior art keywords
dione
dichloro
methyl
preggna
oxycarbonyldicyclohexylmethyloxy
Prior art date
Application number
ZA851927A
Other languages
English (en)
Inventor
Francoise Delevallee
Roger Deraedt
Simone Jouquey
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA851927B publication Critical patent/ZA851927B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
ZA851927A 1984-04-03 1985-03-14 Pharmaceutical composition containing 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxy preggna-1,4-diene-3,20-dione ZA851927B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8405222A FR2561919B1 (fr) 1984-04-03 1984-04-03 Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon

Publications (1)

Publication Number Publication Date
ZA851927B true ZA851927B (en) 1986-04-30

Family

ID=9302777

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA851927A ZA851927B (en) 1984-04-03 1985-03-14 Pharmaceutical composition containing 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxy preggna-1,4-diene-3,20-dione

Country Status (16)

Country Link
US (1) US4614736A (xx)
EP (1) EP0161144B1 (xx)
JP (1) JPS60224615A (xx)
AT (1) ATE41604T1 (xx)
AU (1) AU571073B2 (xx)
CA (1) CA1226817A (xx)
DE (1) DE3568944D1 (xx)
DK (1) DK164478C (xx)
FR (1) FR2561919B1 (xx)
GR (1) GR850815B (xx)
HU (1) HU196122B (xx)
IL (1) IL74642A (xx)
MA (1) MA20388A1 (xx)
OA (1) OA07978A (xx)
PT (1) PT80214B (xx)
ZA (1) ZA851927B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
US20050059583A1 (en) * 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462443A1 (fr) * 1979-07-26 1981-02-13 Roussel Uclaf Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
FR2533928A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
FR2561919A1 (fr) 1985-10-04
AU4080085A (en) 1985-10-10
DK164478C (da) 1992-11-23
US4614736A (en) 1986-09-30
HUT44436A (en) 1988-03-28
DK146785A (da) 1985-10-04
FR2561919B1 (fr) 1986-12-19
MA20388A1 (fr) 1985-10-01
ATE41604T1 (de) 1989-04-15
OA07978A (fr) 1987-01-31
IL74642A (en) 1988-09-30
DE3568944D1 (en) 1989-04-27
PT80214A (en) 1985-05-01
CA1226817A (fr) 1987-09-15
GR850815B (xx) 1985-07-23
IL74642A0 (en) 1985-06-30
DK164478B (da) 1992-07-06
EP0161144B1 (fr) 1989-03-22
AU571073B2 (en) 1988-03-31
HU196122B (en) 1988-10-28
DK146785D0 (da) 1985-04-01
EP0161144A1 (fr) 1985-11-13
PT80214B (en) 1987-02-17
JPS60224615A (ja) 1985-11-09

Similar Documents

Publication Publication Date Title
EP0493362A3 (en) Compositions and kits for the treatment of oral diseases
GB2013495A (en) Therapeutic method for the treatment of hyperlipodaemias and hyperlipoproteinaemias
ZA874635B (en) Novel anti-inflammatory agents,pharmaceutical compositions and methods for reducing inflammation
ZA824233B (en) Therapeutic method and method for making compositions for use therein
EP0147261A3 (en) Medicine and medicinal composition for the treatment and the prevention of skin affections involving an inflammation process
EP0423842A3 (en) Steroids and therapeutic compositions containing same
ZA857081B (en) Composition for the treatment of allergy
EP0069232A3 (en) Purified antineoplaston fractions and methods of treating neoplastic disease
PH12415A (en) 16a,17-cyclopentylidenedioxy-9a-fluoro-11,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate,anti-inflammatory composition and method of use thereof
ZA835787B (en) Treatment and discharge of ash-containing fuel residues
JPS5555200A (en) Steroid compound and medicine composition
ZA851927B (en) Pharmaceutical composition containing 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxy preggna-1,4-diene-3,20-dione
PH18061A (en) Anti-inflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes
ZA831373B (en) Anti-inflammatory and rheumatic composition containing organophosphonate and steriod
GB2188932B (en) Steroidal compounds and process for lengthening the side-chain of certain steroids
DE3362340D1 (en) A pharmaceutical composition and the use thereof for the treatment of inflammation
DE3272384D1 (en) Medicinal composition for the treatment of certain neuroviroses
DE3480706D1 (de) 5-fluoruracilabkoemmlinge sowie medizinische zusammensetzungen die diese enthalten.
JPS5692214A (en) Composition and method for oral adminstration treatment for hemorrhoids
DE3272452D1 (en) Medicinal composition and method of making same
ZA855613B (en) Composition and method for the treatment of hemorrhoids
DK165879C (da) 11beta-chlor-delta15-steroider til anvendelse i antikonceptionspraeparater
PH18966A (en) 19-nor steroids and 19-nor-d-homosteroids,method of use and pharmaceutical composition thereof
JPS57175116A (en) Pharmacological composition for circular alopecia treatment and therapy thereby
ZA79449B (en) Therapeutic method for the treatment of hyperlipoproteinaemias and hyperlipodaemias